Libenzapril

This classification denotes an ace inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QD8496WWYK. European Medicines Agency schedules Libenzapril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08502MIG. Libenzapril generally arises in the molecular formula C18H25N3O5. The term LIBENZAPRIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 2, no. 3, 1988, list 28.) LIBENZAPRIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule libenzapril under HS 29337900 and SITC 51561. As of Q4 2014, LIBENZAPRIL remains the US FDA Preferred Term for this commodity. Libenzapril bears US NLM identifiers UMLS ID C0055225 and NCI Concept Code C81335. SMILES: O=C1N(c2c(CCC1NC(CCCCN)C(=O)O)cccc2)CC(=O)O.